• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 相关脓毒症诱导性中性粒细胞减少症患者弥散性血管内凝血的消退。

Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis-Induced Neutropenia.

机构信息

Department of Medicine, Ospedale Buonconsiglio Fatebenefratelli di Napoli, 80122 Naples, Italy.

Intensive Care Unit, Ospedale Buonconsiglio Fatebenefratelli di Napoli, 80129 Naples, Italy.

出版信息

Medicina (Kaunas). 2021 Jan 24;57(2):106. doi: 10.3390/medicina57020106.

DOI:10.3390/medicina57020106
PMID:33498929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7911171/
Abstract

COVID-19 has been associated with a hypercoagulable state and thrombotic events. Venous thromboembolism has been the most commonly reported type of thrombosis but also arterial thrombosis and disseminated intravascular coagulation in inpatients have been described frequently in several clinical experiences. Patients with COVID-19, because of its tendency to induce leucopenia and overlapping of bacterial infection, may experience sudden disseminated intravascular coagulation (DIC), as in the case that we report here. However, early diagnosis and treatment may be associated with positive resolution of these severe complications.

摘要

COVID-19 与高凝状态和血栓事件有关。静脉血栓栓塞是最常报告的血栓类型,但在几项临床经验中,也经常描述住院患者的动脉血栓形成和弥散性血管内凝血。由于 COVID-19 倾向于诱导白细胞减少和细菌感染重叠,患者可能会像我们在此报告的病例一样,突然发生弥散性血管内凝血 (DIC)。然而,早期诊断和治疗可能与这些严重并发症的积极解决相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/7911171/71b8c9284d52/medicina-57-00106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/7911171/71b8c9284d52/medicina-57-00106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/7911171/71b8c9284d52/medicina-57-00106-g001.jpg

相似文献

1
Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis-Induced Neutropenia.COVID-19 相关脓毒症诱导性中性粒细胞减少症患者弥散性血管内凝血的消退。
Medicina (Kaunas). 2021 Jan 24;57(2):106. doi: 10.3390/medicina57020106.
2
COVID-19 coagulopathy: is it disseminated intravascular coagulation?COVID-19 凝血功能障碍:是弥散性血管内凝血吗?
Intern Emerg Med. 2021 Mar;16(2):309-312. doi: 10.1007/s11739-020-02601-y. Epub 2020 Dec 24.
3
Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.那屈肝素治疗弥漫性血管内凝血的重症 COVID-19 肺炎的潜在机制。
Int J Infect Dis. 2021 Jan;102:529-531. doi: 10.1016/j.ijid.2020.10.093. Epub 2020 Nov 3.
4
Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19.弥散性血管内凝血:一种特别与 COVID-19 相关的致命性全身性疾病。
Dermatol Ther. 2020 Nov;33(6):e14053. doi: 10.1111/dth.14053. Epub 2020 Sep 4.
5
Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review.新型冠状病毒肺炎患者弥漫性血管内凝血的诊断与治疗:范围综述。
Int J Hematol. 2021 Mar;113(3):320-329. doi: 10.1007/s12185-021-03084-z. Epub 2021 Feb 7.
6
A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.COVID-19 引起的同时发生的显性弥漫性血管内凝血和急性双侧肺栓塞的独特病例报告。
Int J Infect Dis. 2021 Mar;104:568-571. doi: 10.1016/j.ijid.2021.01.040. Epub 2021 Jan 21.
7
Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis.COVID-19 孕妇的止血和血栓栓塞并发症:系统评价和批判性分析。
BMC Pregnancy Childbirth. 2021 Feb 5;21(1):108. doi: 10.1186/s12884-021-03568-0.
8
The Impact of COVID-19 Disease on Platelets and Coagulation.新型冠状病毒疾病对血小板和凝血的影响。
Pathobiology. 2021;88(1):15-27. doi: 10.1159/000512007. Epub 2020 Oct 13.
9
COVID-19 versus HIT hypercoagulability.COVID-19 与 HIT 高凝状态。
Thromb Res. 2020 Dec;196:38-51. doi: 10.1016/j.thromres.2020.08.017. Epub 2020 Aug 10.
10
[Pathogenesis, diagnosis, prevention and treatment of disseminated intravascular coagulation syndrome in COVID-19 infection].[新型冠状病毒肺炎感染中弥散性血管内凝血综合征的发病机制、诊断、预防及治疗]
Ter Arkh. 2020 Dec 26;92(11):51-56. doi: 10.26442/00403660.2020.11.000887.

引用本文的文献

1
Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies.SARS-CoV-2、腺病毒和细菌抗原诱导的互补自身抗体与 COVID-19 凝血障碍中的人血蛋白抗原发生交叉反应。
Int J Mol Sci. 2022 Sep 29;23(19):11500. doi: 10.3390/ijms231911500.
2
Thrombotic Disorders and Antithrombotic Treatments Special Issue.血栓性疾病与抗血栓治疗特刊
Medicina (Kaunas). 2022 Feb 2;58(2):229. doi: 10.3390/medicina58020229.
3
Anticoagulated de novo atrial flutter complicated by transitory ischemic attack in fatal COVID-19.

本文引用的文献

1
Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads.血管紧张素转换酶 2、补体系统、激肽释放酶-激肽系统、2 型糖尿病、白细胞介素 6 及其相互作用在复杂的 COVID-19 病理生理学交汇点。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320979097. doi: 10.1177/1470320320979097.
2
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.高流量鼻导管给氧治疗严重新型冠状病毒肺炎所致呼吸衰竭:一项真实世界观察性研究。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963016. doi: 10.1177/1753466620963016.
3
抗凝治疗的初发性心房扑动并发短暂性脑缺血发作,见于致命性新型冠状病毒肺炎病例
Clin Case Rep. 2022 Jan 20;10(1):e05246. doi: 10.1002/ccr3.5246. eCollection 2022 Jan.
4
COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-binding proteins, platelet factor 4, prothrombin, and coagulation factors.COVID-19 凝血功能障碍:人类血液蛋白模拟 SARS-CoV-2 病毒、疫苗蛋白和细菌合并感染诱导自身免疫:细菌和 SARS-CoV-2 的组合协同诱导针对心磷脂、心磷脂结合蛋白、血小板因子 4、凝血酶原和凝血因子的自身抗体。
Bioessays. 2021 Dec;43(12):e2100158. doi: 10.1002/bies.202100158. Epub 2021 Oct 22.
Specific coagulation markers may provide more therapeutic targets in COVID-19 patients receiving prophylactic anticoagulant.对于接受预防性抗凝治疗的新冠肺炎患者,特定的凝血标志物可能提供更多的治疗靶点。
J Thromb Haemost. 2020 Sep;18(9):2428-2430. doi: 10.1111/jth.14988.
4
Rationale for targeting complement in COVID-19.针对 COVID-19 靶向补体的理由。
EMBO Mol Med. 2020 Aug 7;12(8):e12642. doi: 10.15252/emmm.202012642. Epub 2020 Jul 12.
5
ACE2 and COVID-19 and the resulting ARDS.血管紧张素转化酶 2 与 COVID-19 及由此导致的急性呼吸窘迫综合征。
Postgrad Med J. 2020 Jul;96(1137):403-407. doi: 10.1136/postgradmedj-2020-137935. Epub 2020 Jun 10.
6
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.COVID-19 中的细胞因子风暴:发病机制和治疗中使用的抗炎药物概述。
Clin Rheumatol. 2020 Jul;39(7):2085-2094. doi: 10.1007/s10067-020-05190-5. Epub 2020 May 30.
7
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.新冠肺炎患者中性粒细胞与淋巴细胞比值和 D-二聚体的临床意义:中国苏州的一项回顾性研究。
Thromb Res. 2020 Aug;192:3-8. doi: 10.1016/j.thromres.2020.05.006. Epub 2020 May 6.
8
DIC in COVID-19: Implications for prognosis and treatment?新型冠状病毒肺炎中的弥散性血管内凝血:对预后和治疗的影响?
J Thromb Haemost. 2020 Jul;18(7):1798-1799. doi: 10.1111/jth.14878. Epub 2020 Jun 14.
9
COVID-19, ECMO, and lymphopenia: a word of caution.新型冠状病毒肺炎、体外膜肺氧合与淋巴细胞减少:一则警示
Lancet Respir Med. 2020 Apr;8(4):e24. doi: 10.1016/S2213-2600(20)30119-3. Epub 2020 Mar 13.
10
Disseminated intravascular coagulation: an update on pathogenesis and diagnosis.弥散性血管内凝血:发病机制与诊断的最新进展
Expert Rev Hematol. 2018 Aug;11(8):663-672. doi: 10.1080/17474086.2018.1500173. Epub 2018 Jul 20.